Pediatric Endocrinology News

The incidence of severe diabetic ketoacidosis among children presenting with new-onset type 1 diabetes doubled during the COVID-19 pandemic period compared with data from 2019, according to data published in Pediatric Diabetes.

Transgender adolescents treated with gender-affirming hormone therapy early in puberty experience bone development more similar to that of their experienced gender compared with their gender assigned at birth, according to study data.

Children with a high genetic risk for developing type 1 diabetes are at an increased risk for the disease if they have overweight or obesity from age 2 to 10 years, according to trial data published in Diabetologia.

Teenage boys with obesity gained more than 8 pounds on average vs. about 2.6 pounds for girls, during Italy’s first COVID-19 lockdown in the spring of 2020, primarily due to spending more time video gaming, according to study data.

Telemedicine visits for gender-affirming care in minors rapidly increased during the COVID-19 pandemic and may be able to expand access to care in the future, according to data from two studies published in Transgender Health.

Children with type 1 diabetes using a hybrid closed-loop system and their parents do not report an increase in diabetes-related burden compared with those using a sensor-augmented insulin pump, according to trial data.

Arkansas on Tuesday became the first state to outlaw any gender-affirming medical treatments for minors who may be transgender, overriding a veto from the governor and prompting outcry from providers and advocates.

Subcutaneous testosterone was effective in allowing transgender male and gender-diverse youths to reach recommended testosterone levels and stop menses, with few severe adverse events, according to findings published in Transgender Health.

Children with a common form of skeletal dysplasia saw persistent and sustained improvements in annualized growth velocity with an investigational analogue of C-type natriuretic peptide, according to new data from an extension study.

An updated evidence-based guideline supports global neonatal screening for congenital hypothyroidism to optimize detection, diagnosis, treatment and follow-up of children with the condition.